Found 0 matching trials
Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning
N/AThis study aims to develop and validate a robust machine learning-based pre...
Status
Active Not Recruiting
Location
Peking University People's Hospital
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer
PHASE2This study is conducted to evaluate efficacy and safety of neoadjuvant chem...
Dosimetric Limitation of Pelvic Bone and Peritoneal Space in Rectal Cancer Patients During Chemoradiotherapy
NAThis project first retrospectively analyzes the intestinal dose indicators ...
Location
Fudan University Shanghai Cancer Center
Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer
PHASE2This study is a phase II, single arm, controlled, open label internal pilot...
Location
Odette Cancer Centre, Sunnybrook Health Sciences Centre
The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome
NAPancreatic cancer is a highly lethal disease. Patients with resectable or b...
Location
Academic Medical Center
Exercise Training in Colorectal Cancer Patients
NANeoadjuvant chemoradiotherapy (NACRT) prior to surgery for lower gastrointe...
Location
Aintree University Hospitals
Efficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLC
PHASE2This study is a phase 2 open-label, single-center clinical study to evaluat...
Location
Hunan Provincal Tumor Hospital
Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer
PHASE2Preoperative chemoradiation leads to increased pelvic control and overall s...
Location
UT M. D. Anderson Cancer Center
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
PHASE2Esophageal cancer, which has a low 5-year overall survival rate (\<20%) is ...
Location
VA Palo Alto Health Care System, Palo Alto, CA
Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer
N/ABackgrounds: A multicenter randomized phase III trial (NCT02605265) proved ...
Location
Fudan University Shanghai Cancer Center